Skip to content
Est. 1998 proudly celebrating our 27th year of championing American business
American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

Evogene Ltd.

  • Public · NASDAQ: EVGN
  • 52 employees
$6.4MMarket cap
52Employees
EVGNNASDAQ
2008IPO

About Evogene Ltd.

Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the industrial segment, followed by Agriculture.

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Reported figures

Financial summary

Market cap
$6.4M
NASDAQ: EVGN

15-minute delayed · data by Polygon.io

Market cap
$6.4M
Open
Day range
Prev close
Volume
IPO date
Mar 5, 2008

Market data by Polygon.io · prices are 15-minute delayed

No reviews yet. Be the first to review Evogene Ltd..

Write a review
Explore

Similar companies

Browse all →